Momelotinib Dihydrochloride Monohydrate

Records for this ingredient, by country (identity only).

ATC — · 3 markets · 9 records

Momelotinib Dihydrochloride Monohydrate 3 markets · 9 records Forms
Filters
MarketAU 3SG 3CZ 3

AU 3 records · 3 shown of 3 Source TGA · Data as of 2026-10-28 · includes records with unknown status (not proof of sale)

  • 243.88 mgtabletOMJJARA momelotinib (as dihydrochloride monohydrate) 100 mg film-coated tablet bottle unknown
  • 182.91 mgtabletOMJJARA momelotinib (as dihydrochloride monohydrate) 100 mg film-coated tablet bottle unknown
  • 121.94 mgtabletOMJJARA momelotinib (as dihydrochloride monohydrate) 100 mg film-coated tablet bottle unknown

SG 3 records · 3 shown of 3 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

CZ 3 records · 0 shown of 0 Source Státní ústav pro kontrolu léčiv (S · Data as of 2026-11-01 · some records have no stated strength

3 records · 0 manufacturers 3 registros · 0 fabricantes 3 个记录 · 0 个厂家 3 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名Omjjara 100mg tablets ×27

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.